Cargando…
Lipidated peptides derived from intracellular loops 2 and 3 of the urotensin II receptor act as biased allosteric ligands
Over the last decade, the urotensinergic system, composed of one G protein-coupled receptor and two endogenous ligands, has garnered significant attention as a promising new target for the treatment of various cardiovascular diseases. Indeed, this system is associated with various biomarkers of card...
Autores principales: | Nassour, Hassan, Hoang, Tuan Anh, Martin, Ryan D., Dallagnol, Juliana C.C., Billard, Étienne, Létourneau, Myriam, Novellino, Ettore, Carotenuto, Alfonso, Allen, Bruce G., Tanny, Jason C., Fournier, Alain, Hébert, Terence E., Chatenet, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Biochemistry and Molecular Biology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8424217/ https://www.ncbi.nlm.nih.gov/pubmed/34389356 http://dx.doi.org/10.1016/j.jbc.2021.101057 |
Ejemplares similares
-
Update on the urotensinergic system: new trends in receptor localization, activation, and drug design
por: Chatenet, David, et al.
Publicado: (2013) -
Endogenous Urotensin II Selectively Modulates Erectile Function through eNOS
por: d'Emmanuele di Villa Bianca, Roberta, et al.
Publicado: (2012) -
Design of a peptidic inhibitor that targets the dimer interface of a prototypic galectin
por: Vladoiu, Maria Claudia, et al.
Publicado: (2015) -
A new therapeutic approach to erectile dysfunction: urotensin-II receptor high affinity agonist ligands
por: di Villa Bianca, Roberta d’Emmanuele, et al.
Publicado: (2015) -
Urotensin II receptor determines prognosis of bladder cancer regulating cell motility/invasion
por: Franco, Renato, et al.
Publicado: (2014)